XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Preferred Stock
Additional paid-in capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Treasury stock
Common shares outstanding at Dec. 31, 2021       8,457,564              
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures       47,864              
Issuance of common stock under the employee stock purchase plan, shares       1,380              
Treasury stock purchased, shares       (18,223)              
Common shares outstanding at Mar. 31, 2022       8,488,585              
Beginning balance at Dec. 31, 2021 $ 232,422     $ 93 $ 0 $ 85,797 $ 170,020     $ (1,457) $ (22,031)
Net income 8,672           8,672        
Other comprehensive income (loss) (6,406)                 (6,406)  
Stock Issued During Period, Value, New Issues 11,992       11,992            
Share-based compensation - restricted shares 609     1   608          
Issuance of common stock under the employee stock purchase plan 40         40          
Stock Issued During Period, Value, Treasury Stock Reissued 0         (1,002)         1,002
Preferred stock dividend 0                    
Cash Dividends (1,670)           (1,670)        
Treasury stock purchased (608)                   (608)
Ending balance at Mar. 31, 2022 $ 245,051     $ 94 11,992 85,443 177,022     (7,863) (21,637)
Common shares outstanding at Dec. 31, 2022 8,362,085     8,362,085              
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures       (426)              
Issuance of common stock under the employee stock purchase plan, shares 1,005     1,005              
Treasury stock purchased, shares       (56,394)              
Common shares outstanding at Mar. 31, 2023 8,306,270     8,306,270              
Beginning balance at Dec. 31, 2022 $ 260,640 $ 1,353 $ 259,287 $ 94 11,992 87,512 203,507 $ (1,353) $ 202,154 (15,310) (27,155)
Net income 8,979           8,979        
Other comprehensive income (loss) 1,639                 1,639  
Share-based compensation - restricted shares 634     0   634          
Issuance of common stock under the employee stock purchase plan 27         27          
Preferred stock dividend 219           219        
Cash Dividends (1,906)           (1,906)        
Treasury stock purchased (1,860)                   (1,860)
Ending balance at Mar. 31, 2023 $ 266,581     $ 94 $ 11,992 $ 88,173 $ 209,008     $ (13,671) $ (29,015)